Observational studyBMC medicine2026
Sex-specific signatures of fetal programming for gestational diabetes mellitus in umbilical cord: A cohort study from Tanzania.
Observational study in BMC medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02191683 (Foetal Exposure and Epidemiological Transition), which is not on this map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Foetal Exposure and Epidemiological Transition: the Role of Anaemia in Early Life for Non-communicable Diseases in Later Life
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
18 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundGestational diabetes mellitus (GDM) is defined as glucose intolerance first recognized during pregnancy. Offspring of GDM mothers have an increased risk of developing type 2 diabetes (T2D), obesity, and other metabolic disorders later in life.
methodsWe analyzed metabolic, genetic, epigenetic, and transcriptional profiles in umbilical cord blood (UCB) from male and female offspring of GDM mothers versus normoglycemic controls in Tanzania. We constructed polygenic and methylation risk scores for T2D and GDM to assess whether diabetes-related susceptibility is detectable at birth. We identified differentially expressed genes (DEGs) and corresponding epigenome-wide alterations in GDM-exposed UCB. We then integrated genetic (PGS), epigenetic (MRS), and transcriptomic (DEG) data to identify convergent molecular signatures of GDM exposure. We examined their associations with neonatal anthropometry and cord insulin levels to infer potential effects on early growth. We further assessed DEG relevance by examining expression in human fetal and adult islets and by reviewing mouse-knockout data to explore possible roles in β-cell development or function.
resultsOffspring of GDM mothers showed sex-specific differences in neonatal anthropometry, particularly among females, who exhibited greater adiposity and growth measures. Female offspring also displayed higher PGS for T2D, especially β-cell dysfunction, and a MRS for GDM/T2D associated with elevated cord insulin. We identified 36 DEGs in GDM-exposed UCB overall, with a striking sex-specific pattern (273 DEGs in females vs. 4 in males). Several DEGs and associated DNA methylation (DNAm) sites correlated with neonatal anthropometry, particularly in females, indicating putative fetal programming signatures. These signals showed convergence across genetic risk, DNA methylation, and gene expression layers. The expression of SESN3, HMBS, NUTM2D, and MAN2A2 associated with insulin levels. MAN2A2 expression also associated with birth weight and length in female offspring. The SLC4A1 gene showed fetal pancreas-specific expression and co-expression with key pancreatic developmental genes, suggesting a role in pancreatic development.
conclusionsWe identified integrated multi-omic signatures of GDM exposure in offspring at birth, with markedly stronger effects in females. These genes and pathways may contribute to fetal metabolic programming in this understudied Tanzanian population, offering new insights into biological mechanisms that may influence early development.
trial registrationClinicalTrials.gov NCT02191683 Registered 2 July 2014.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.